References
Perucca E (1996) The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 42: 531–533
Hooper WD, Dickinson RG, Dunstan PR, et al (1987) Oxcarbazepine: preliminary clinical and pharmacokinetic studies on a new anticonvulsant. Clin Exp Neurol 24:105–112
Gram L (1996) Pharmacokinetics of new antiepileptic drugs. Epilepsia 37:S12–S16
Fraser AD (1996) New drugs for the treatment of epilepsy. Clin Biochem 29:97–110
May TW, Rambeck B, Jurgens U (1999) Influence of oxcarbazepine and methsuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: results of a retrospective study. Ther Drug Monit 21:175–181
Levert H, Odou P, Robert H (2002) Simultaneous determination of four antiepileptic drugs in serum by high-performance liquid chromatography. Biomed Chromatogr 16:19–24
Barcs G, Walker EB, Elger CE, et al (2000) Oxcarbazepine placebo-controlled, dose ranging trial in refractory partial epilepsy. Epilepsia 41:1597–1607
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guénault, N., Odou, P. & Robert, H. Increase in dihydroxycarbamazepine serum levels in patients co-medicated with oxcarbazepine and lamotrigine. Eur J Clin Pharmacol 59, 781–782 (2003). https://doi.org/10.1007/s00228-003-0686-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-003-0686-z